New Publication Expands Knowledge of Wolman Disease and Reports a Novel LIPA Variant
A recent article published in Frontiers in Pediatrics reports on two Chinese infants diagnosed with Wolman Disease, the most severe infantile form of Lysosomal Acid Lipase Deficiency (LAL-D).
The publication contributes to the scientific understanding of this ultra-rare disease by describing a previously unreported LIPA variant (c.285G>T; p.Trp95Cys). This finding expands the known molecular spectrum of LAL-D and highlights the importance of continued research into the genetic causes of the disease.
Beyond the significance of this novel variant, the article highlights an urgent reality: the need for greater awareness and earlier recognition of Wolman Disease.
Both infants presented with clinical features commonly associated with the disease, including hepatosplenomegaly, abdominal distension, failure to thrive, hematological abnormalities, dyslipidemia, and adrenal involvement. Despite medical care, the disease progressed rapidly, and both infants died during the first months of life due to progressive multi-organ failure.
These cases underline the importance of ensuring that pediatricians, neonatologists, gastroenterologists, hepatologists, geneticists, and other healthcare professionals are familiar with the warning signs of LAL-D. Recognizing the disease and including it in the differential diagnosis can make the difference between reaching a diagnosis in time or when it is already too late.
Early identification is particularly important because a disease-specific treatment is available and may alter the natural course of a condition that is otherwise rapidly progressive and often fatal during infancy.
At LAL-D Patient Organization, we would like to sincerely thank the authors for their valuable contribution to the understanding of Wolman Disease and Lysosomal Acid Lipase Deficiency. Every new scientific discovery helps improve diagnosis, care, and future outcomes for patients and families affected by this condition.
We also extend our deepest sympathy, respect, and support to the families who suffered the devastating loss of their children. Their stories remind us why raising awareness, promoting earlier diagnosis, and improving access to treatment remain essential goals for the entire LAL-D community.
📖 Original article: Read the publication in Frontiers in Pediatrics
